coactiv+™ Antimicrobial Wound Gel— 510(k) K241809

Substantially Equivalent

Kane Biotech, Inc.

FDA 510(k) clearance K241809 for coactiv+™ Antimicrobial Wound Gel, Substantially Equivalent on 2024-07-19. Applicant: Kane Biotech, Inc..

Clearance details

Applicant
Kane Biotech, Inc.
Product code
Code FRO
Advisory panel
Unknown
Date received
Decision date
Decision
Substantially Equivalent
Clearance type
Special
Location
Winnipeg, CA
Download summary PDFView on FDA.gov ↗

Adverse events under product code FRO

product code FRO
Death
30
Injury
653
Malfunction
479
Other
11
Total
1,173

Source: openFDA MAUDE database, through . Counts aggregate all devices under this product code, not just this specific clearance. Reports are submissions to FDA, not validated events. Search MAUDE directly →

Data sourced from openFDA. This site is unofficial and independent of the FDA.